• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Jazz Pharmaceuticals PLC

+ Add to Watchlist


162.9200 USD 0.2100 0.13%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Jazz Pharmaceuticals PLC (JAZZ)

Open: 162.8800 Day's Range: 160.4900 - 163.9899 Volume: 668,820
Previous Close: 162.7100 52wk Range: 80.4000 - 176.6010 1-Yr Rtn: +85.79%

Stock Chart for JAZZ

No chart data available.
  • JAZZ:US 162.9200
  • 1D
  • 1M
  • 1Y
Interactive JAZZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JAZZ

Current P/E Ratio (ttm) 75.9316
Estimated P/E(12/2014) 19.9804
Relative P/E vs. SPX 4.2316
Earnings Per Share (USD) (ttm) 2.1456
Est. EPS (USD) (12/2014) 8.1540
Est. PEG Ratio 0.9293
Market Cap (M USD) 9,811.23
Shares Outstanding (M) 60.22
30 Day Average Volume 905,210
Price/Book (mrq) 7.6669
Price/Sale (ttm) 9.4869
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JAZZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for JAZZ

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Bruce C CozaddChairman/CEO/Co-FounderRussell J CoxExec VP/COO
Suzanne Sawochka HooperExec VP/General CounselJeffrey K Tobias "Jeff"Exec VP:Research & Development
More Company Profile & Key Executives for JAZZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil